Progressive digital necrosis during gemcitabine/nab-paclitaxel chemotherapy in a patient with pancreatic cancer

Dermatol Ther. 2022 Apr;35(4):e15353. doi: 10.1111/dth.15353. Epub 2022 Feb 12.

Authors

Yuri Shimizu¹, Chika Ohata¹

Affiliation

¹ Department of Dermatology, Osaka General Medical Center, Osaka, Japan.

PMID: 35108430
DOI: 10.1111/dth.15353

No abstract available

Publication types

Letter

MeSH terms

Albumins* / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Deoxycytidine / analogs & derivatives
Gemcitabine
Humans
Necrosis / chemically induced
Necrosis / drug therapy
Paclitaxel / adverse effects
Pancreatic Neoplasms* / drug therapy

Substances

130-nm albumin-bound paclitaxel
Albumins
Deoxycytidine
Paclitaxel
Gemcitabine